IP Library Assignment 047073/0116
Patent Assignment
Reel/Frame 047073/0116

Release and Reassignment of Security Interest Recorded at Reel/Frame 44275/0032

Recorded: 2018-09-13 Pages: 5
Assignor
NXT CAPITAL, LLC
Executed: 2018-08-02
Assignee
GLEN RESEARCH, LLC
22825 DAVIS DRIVE, STERLING, VIRGINIA, 20164
Covered Properties (4)
Universal Supports for Oligonucleotide Synthesis
Patent: 6,770,754 →
Application: 09/995,785 →
Publication: US 2002/0137855
Fluorescent Nitrogenous Base and Nucleosides Incorporating Same
Patent: 7,144,995 →
Application: 10/382,754 →
Publication: US 2004/0009933
Universal Supports for Oligonucleotide Synthesis
Patent: 7,491,817 →
Application: 10/851,289 →
Publication: US 2005/0250116
Novel Reagents Utilizing A Serinol Scaffold For Labeling Synthetic Oligonucleotides
Patent: 8,394,948 →
Application: 12/891,888 →
Publication: US 2011/0077389
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 1, 2017
From: GLEN RESEARCH, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 044275/0032 →
Security Agreement Aug 2, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 046708/0095 →
Security Agreement Aug 3, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 046702/0651 →
Entity Conversion Oct 16, 2020
From: GLEN RESEARCH CORPORATION
To: GLEN RESEARCH, LLC
Reel/Frame 054094/0001 →
Security Agreement Oct 19, 2020
From: MARAVAI LIFE SCIENCES, INC.; TRILINK BIOTECHNOLOGIES, LLC; VECTOR LABORATORIES, INC.; GLEN RESEARCH, LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 054118/0848 →
Release of First Lien Security Interest Oct 19, 2020
From: JPMORGAN CHASE BANK, N.A.
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0751 →
Release of Second Lien Security Interest Oct 19, 2020
From: ANTARES CAPITAL LP
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0763 →